Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Gram-Negative Bacterial Infections × Colistin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 2 Sepsis 1 Neutropenia 1 Hematological Infection 1 Gram-Negative Bacterial Infections 1 Colorectal Neoplasms 1 Anastomotic Leak 1

Interventions

colistinmethanesulfonic acid 1 ceftolozane, tazobactam drug combination 1 Colistin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03397914 2020-09-16

Effect of Different Colistin Doses on Clinical Outcome of Pediatric Cancer Patients With Gram Negative Infections

National Cancer Institute, Egypt

Phase 4 Completed

Neoplasms, Gram-Negative Bacterial Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡